Advertisement
JOGC

Medical Management of Pain Associated With Endometriosis

        This paper is only available as a PDF. To read, Please Download here.

        REFERENCES

          • Sutton C.J.
          • Ewan S.P.
          • Whitelaw N.
          • Haines P.
          Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis.
          Fertil Steril. 1994; 62: 696-700
          • Jones K.D.
          • Haines P.
          • Sutton C.J.
          Long-term follow-up of a controlled trial of laser laparoscopy for pelvic pain.
          JSLS. 2001; 5: 111-115
          • Abbott J.A.
          • Hawe J.
          • Clayton R.D.
          • Garry R.
          The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2–5 year follow-up.
          Hum Reprod. 2003; 18: 1922-1927
          • Harada T.
          • Momoeda M.
          • Taketani Y.
          • Hiroshi H.
          • Terakawa N.
          Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial.
          Fertil Steril. 2008; 90: 1583-1588
          • Jenkins T.R.
          • Liu C.Y.
          • White J.
          Does response to hormonal therapy predict presence or absence of endometriosis?.
          J Minim Invasive Gynecol. 2008; 15: 82-86
          • Vercellini P.
          • Frontino G.
          • De Giorgi O.
          • Pietropaolo G.
          • Pasin R.
          • Crosignani P.G.
          Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen.
          Fertil Steril. 2003; 80: 560-563
          • Coffee A.L.
          • Sulai P.J.
          • Kuehl T.J.
          Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.
          Contraception. 2007; 75: 444-449
          • Bulun S.E.
          • Cheng Y.H.
          • Yin P.
          • Imir G.
          • Utsunomiya H.
          • Attar E.
          • et al.
          Progesterone resistance in endometriosis: link to failure to metabolize estradiol.
          Mol Cell Endocrinol. 2006; 248: 94-103
          • Bulun S.E.
          Endometriosis.
          N Engl J Med. 2009; 360: 268-279
          • Muneyyirci-Delate O.
          • Karacan M.
          Effect of norethindrone acetate in the treatment of symptomatic endometriosis.
          Int J Fertil Womens Med. 1998; 43: 24-27
          • Sasagawa S.
          • Shimizu Y.
          • Kami H.
          • Takeuchi T.
          • Mita S.
          • Imada K.
          • et al.
          Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.
          Steroids. 2008; 73: 222-231
          • Strowitzki T.
          • Marr J.
          • Gerlinger C.
          • Faustmann T.
          • Seitz C.
          Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.
          Hum Reprod. 2010; 25: 633-641
          • Harada T.
          • Momoeda M.
          • Taketani Y.
          • Aso T.
          • Fukunaga M.
          • Hagino H.
          • et al.
          Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial.
          Fertil Steril. 2009; : 675-681
          • Cosson M.
          • Querleu D.
          • Donnez J.
          • Madelenat P.
          • Konickx P.
          • Audebert A.
          • et al.
          Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study.
          Fertil Steril. 2002; 77: 684-692
          • Strowitzki T.
          • Seitz C.
          • Marr J.
          • Gerlinger C.
          • Faustmann T.
          Efficacy of dienogest for the treatment of endometriosis: a 24-week, randomised, open-label trial versus leuprolide acetate. 2009; (Amsterdam)
          • Schlaff W.D.
          • Carson S.A.
          • Luciano A.
          • Ross D.
          • Bergqvist A.
          Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
          Fertil Steril. 2006; 85: 314-325
          • Crosignani P.G.
          • Luciano A.
          • Ray A.
          • Bergqvist A.
          Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain.
          Hum Reprod. 2006; 21: 248-256
          • Behamondes L.
          • Petta C.A.
          • Fernandes A.
          • Monteiro I.
          Use of levonogesterol-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
          Contraception. 2007; 75: S134-S139
          • Petta C.A.
          • Ferriani R.A.
          • Abrao M.S.
          • Hassan D.
          • Rosa E.
          • Silva J.C.
          • et al.
          Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
          Hum Reprod. 2005; 20 (Epub 2005 Mar 24): 1993-1998
          • Vercellini P.
          • Aimi G.
          • Panazza S.
          • De Giorgi O.
          • Pesole A.
          • Crosignani P.G.
          A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study.
          Fertil Steril. 1999; 72: 505-508
          • Jain S.
          • Dalton M.E.
          Chocolate cysts from ovarian follicles.
          Fertil Steril. 1999; 72: 852-856
          • Fedele L.
          • Bianchi S.
          • Zanconato G.
          • Portuese A.
          • Raffaelli R.
          Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis.
          Fertil Steril. 2001; 75: 485-488
          • Dmowksi W.P.
          • Scholer H.F.
          • Mahesh V.B.
          • Greenblatt R.B.
          Danazol—a synthetic steroid derivative with interesting physiologic properties.
          Fertil Steril. 1971; 22: 9-18
          • Selak V.
          • Farquhar C.
          • Prentice A.
          • Singla A.
          Danazol for pelvic pain associated with endometriosis.
          Cochrane Database Syst Rev. 2007; (CD000068)
          • Packard C.J.
          • Shepherd J.
          Action of danazol on plasma lipids and lipoprotein metabolism.
          Acta Obstet Gynecol Scand Suppl. 1994; 159: 35-40
          • Cottreau C.M.
          • Ness R.B.
          • Modugno F.
          • Allen G.O.
          • Goodman M.T.
          Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer.
          Clin Cancer Res. 2003; 9: 5142-5144
          • Razzi S.
          • Luisi S.
          • Calonaci F.
          • Altomare A.
          • Bocchi C.
          • Patraglia F.
          Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis.
          Fertil Steril. 2007; 88: 789-794
          • Barbieri R.L.
          Hormone treatment of endometriosis: the estrogen threshold hypothesis.
          Am J Obstet Gynecol. 1992; 166: 740-745
          • Surrey E.S.
          • Hornstein M.D.
          Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up.
          Obstet Gynecol. 2002; 99: 709-719
          • Mitwally M.F.
          • Gotlieb L.
          • Casper R.F.
          Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome.
          Menopause. 2002; 9: 236-241
          • Hornstein M.D.
          • Surrey E.S.
          • Weisberg G.W.
          • Casino L.A.
          Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study.
          Lupron Add-Back Study Group. Obstet Gynecol. 1998; 91: 16-24
          • Zupi E.
          • Marconi D.
          • Sbracia M.
          • Zullo F.
          • De Vivo B.
          • Exacustos C.
          • et al.
          Add-back therapy in the treatment of endometriosis-associated pain.
          Fertil Steril. 2004; 82: 1303-1308
          • Bedaiwy M.A.
          • Casper R.F.
          Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain.
          Fertil Steril. 2006; 86: 220-222
          • Casper R.F.
          Estrogen with interrupted progestin HRT: a review of experimental and clinical studies.
          Maturitas. 2000; 34: 97-108
          • Bulun S.E.
          • Zeitoun K.M.
          • Takayama K.
          • Sasano H.
          Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance.
          J Mol Endocrinol. 2000; 25: 35-42
          • Ailawadi R.K.
          • Jobanputra S.
          • Kataria M.
          • Gurates B.
          • Bulun S.E.
          Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.
          Fertil Steril. 2004; 81: 290-296
          • Amsterdam L.L.
          • Gentry W.
          • Jobanputra S.
          • Wolf M.
          • Rubin S.D.
          • Bulun S.E.
          Anastrazole and oral contraceptives: a novel treatment for endometriosis.
          Fertil Steril. 2005; 84: 300-304
          • Higgins M.J.
          • Davidson N.E.
          What is the current status of ovarian suppression/ ablation in women with premenopausal early-stage breast cancer?.
          Curr Oncol Rep. 2009; 11: 45-50